Prelude Capital Management’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-18,300
| Closed | -$288K | – | 1199 |
|
|
2025
Q4 | $288K | Buy |
18,300
+549
| +3% | +$9.8K | 0.02% | 813 |
|
|
2025
Q3 | $344K | Buy |
+17,751
| New | +$347K | 0.03% | 662 |
|
|
2023
Q2 | – | Sell |
-2,960
| Closed | -$246K | – | 1108 |
|
|
2023
Q1 | $246K | Buy |
+2,960
| New | +$279K | 0.01% | 753 |
|
|
2022
Q1 | – | Sell |
-9,424
| Closed | -$1.15M | – | 1785 |
|
|
2021
Q4 | $1.15M | Buy |
+9,424
| New | +$1.05M | 0.03% | 540 |
|
|
2021
Q3 | – | Sell |
-14,962
| Closed | -$1.45M | – | 1707 |
|
|
2021
Q2 | $1.45M | Sell |
14,962
-2,103
| -12% | -$182K | 0.04% | 435 |
|
|
2021
Q1 | $1.26M | Sell |
17,065
-481
| -3% | -$35.8K | 0.03% | 524 |
|
|
2020
Q4 | $1.2M | Buy |
17,546
+5,584
| +47% | +$364K | 0.03% | 421 |
|
|
2020
Q3 | $699K | Buy |
+11,962
| New | +$630K | 0.03% | 352 |
|
|
2020
Q1 | – | Sell |
-358
| Closed | -$22K | – | 1407 |
|
|
2019
Q4 | $22K | Buy |
+358
| New | +$21.2K | ﹤0.01% | 1562 |
|
|
2019
Q1 | – | Sell |
-135
| Closed | -$8K | – | 1738 |
|
|
2018
Q4 | $8K | Buy |
+135
| New | +$7.57K | ﹤0.01% | 1402 |
|
|
2018
Q1 | – | Sell |
-510
| Closed | -$25K | – | 1478 |
|
|
2017
Q4 | $25K | Buy |
+510
| New | +$23.2K | ﹤0.01% | 1082 |
|
|
2017
Q3 | – | Sell |
-300
| Closed | -$12K | – | 1599 |
|
|
2017
Q2 | $12K | Sell |
300
-415
| -58% | -$15.9K | ﹤0.01% | 1357 |
|
|
2017
Q1 | $29K | Sell |
715
-3,036
| -81% | -$119K | ﹤0.01% | 1200 |
|
|
2016
Q4 | $144K | Sell |
3,751
-3,771
| -50% | -$129K | 0.02% | 698 |
|
|
2016
Q3 | $240K | Buy |
7,522
+4,078
| +118% | +$155K | 0.03% | 510 |
|
|
2016
Q2 | $138K | Buy |
3,444
+244
| +8% | +$9.03K | 0.02% | 627 |
|
|
2016
Q1 | $108K | Sell |
3,200
-1,028
| -24% | -$29.4K | 0.02% | 737 |
|
|
2015
Q4 | $131K | Buy |
+4,228
| New | +$125K | 0.02% | 712 |
|
|
2015
Q3 | – | Sell |
-438
| Closed | -$14K | – | 1459 |
|
|
2015
Q2 | $14K | Sell |
438
-1,507
| -77% | -$39.4K | ﹤0.01% | 1512 |
|
|
2015
Q1 | $45K | Buy |
+1,945
| New | +$40.2K | 0.01% | 1340 |
|
|
2014
Q2 | – | Sell |
-9,400
| Closed | -$129K | – | 1885 |
|
|
2014
Q1 | $129K | Buy |
+9,400
| New | +$135K | 0.02% | 909 |
|
Other funds holding AMN
VCM
VPM
Prelude Capital Management's AMN Position: Q1 2026 in Review
Prelude Capital Management sold out of AMN Healthcare (AMN) in Q1 2026, closing a stake of 18,300 shares — an estimated $288K sold.
Prelude Capital Management first reported a position in AMN in Q1 2014 and held it in 21 quarters. The position peaked at $1.45M in Q2 2021. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.
- Prelude Capital Management reported no remaining AMN Healthcare position as of Q1 2026 after selling out during the quarter.
- Prelude Capital Management sold 18,300 AMN Healthcare shares in Q1 2026, an estimated $288K.
- Prelude Capital Management first reported a position in AMN Healthcare in Q1 2014 and held it in 21 quarters.
- Prelude Capital Management's AMN Healthcare position peaked at $1.45M in Q2 2021.
- 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.